Skip to content

Early-bird registration discount for 2023 Annual Ataxia Conference ending soon. LEARN MORE!

National Ataxia Foundation

Accelerate!

Blog

National Ataxia Foundation

NAF Supports FARA’s Call to Action

Friedreich’s Ataxia Research Alliance (FARA) is encouraging Reata Pharmaceuticals to submit a New Drug Application (NDA) for Omaveloxolone, which recently completed a Phase III clinical trial as a treatment for Read More…

Print Friendly, PDF & Email

2019 NAF Funded Research Results

Below are lay summaries submitted for research completed in fiscal year 2019. Each study received a grant from NAF to support their research. To check out more information, click the Read More…

Print Friendly, PDF & Email
Print Friendly, PDF & Email
Translate »

Are you ready for fun and learning at the largest Ataxia conference of the year?

2023 Annual Ataxia Conference: Partnering for Progress

Join us to connect, learn, and take action toward accelerating treatment development!